Quantity size:
0.2ml
Concentration:
1mg/ml GATA结合蛋白2抗体 Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Members of the GATA family share a conserved zinc finger DNA-binding domain and are capable of binding the WGATAR consensus sequence. GATA-1 is erythroid-specific and is responsible for the regulated transcription of erythroid genes. It is an essential component in the generationGATA结合蛋白2抗体 of the erythroid lineage. GATA-2 is expressed in embryonic brain and liver, HeLa and endothelial cells, as well as in erythroid cells. Studies with a modified GATA consensus sequence, AGATCTTA, have shown that GATA-2 and GATA-3 recognize this mutated consensus while GATA-1 has poor recognition of this sequence. This indicates broader regulatory capabilities of GATA-2GATA结合蛋白2抗体 and GATA-3 than GATA-1. GATA-3 is highly expressed in T lymphocytes. GATA-4, GATA-5 and GATA-6 comprise a subfamily of transcription factors. Both GATA-4 and GATA-6 are found in heart, pancreas and ovary; lung and liver tissues exhibit GATA-6, but not GATA-4 expression. GATA-5 expression has been observed in differentiated heart and gut tissues and is present throughout the course of development in the heart. Although expression patterns of the various GATA transcription factors may overlap, it is not yet apparent how the GATA factors are able to discriminate in binding their appropriate target sites.
GATA结合蛋白2抗体Also known as:
GATA-2; GATA 2; GATA Binding Protein 2; GATA-binding protein 2; Gata2; GATA2_HUMAN; MGC2306; NFE 1B; NFE1B.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Chicken, Pig, Cow, Horse, Rabbit, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human GATA-2.
●
Predicted Molecular Weight: 53kDa.
GATA结合蛋白2抗体Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl726Mu01转甲状腺素蛋白(TTR)多克隆抗体Polyclonal Antibody to Transthyretin (TTR)
kl726Ra01转甲状腺素蛋白(TTR)多克隆抗体Polyclonal Antibody to Transthyretin (TTR)
kl313Hu01抗凝血酶(AT)多克隆抗体Polyclonal Antibody to Antithrombin (AT)
kl313Mu01抗凝血酶(AT)多克隆抗体Polyclonal Antibody to Antithrombin (AT)
kl313Ra01抗凝血酶(AT)多克隆抗体Polyclonal Antibody to Antithrombin (AT)
kl820Hu01凝血因子Ⅱ(F2)多克隆抗体Polyclonal Antibody to Coagulation Factor II (F2)
kl820Mu01凝血因子Ⅱ(F2)多克隆抗体Polyclonal Antibody to Coagulation Factor II (F2)
kl820Ra01凝血因子Ⅱ(F2)多克隆抗体Polyclonal Antibody to Coagulation Factor II (F2)
kl353Ge01晚期糖基化终末产物(AGE)多克隆抗体Polyclonal Antibody to Advanced Glycation End Product (AGE)
kl929Hu01视黄醇结合蛋白4(RBP4)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 4, Plasma (RBP4)
kl929Mu01视黄醇结合蛋白4(RBP4)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 4, Plasma (RBP4)
kl929Ra01视黄醇结合蛋白4(RBP4)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 4, Plasma (RBP4)
kl367Hu01视黄醇结合蛋白3(RBP3)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 3, Interstitial (RBP3)
kl367Mu01视黄醇结合蛋白3(RBP3)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 3, Interstitial (RBP3)
kl367Ra01视黄醇结合蛋白3(RBP3)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 3, Interstitial (RBP3)
kl377Hu01视黄醇结合蛋白2(RBP2)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 2, Cellular (RBP2)
kl377Mu01视黄醇结合蛋白2(RBP2)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 2, Cellular (RBP2)
kl377Ra01视黄醇结合蛋白2(RBP2)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 2, Cellular (RBP2)
kl400Hu01视黄醇结合蛋白1(RBP1)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 1, Cellular (RBP1)
更多
企业名称
上海康朗生物科技有限公司
企业信息已认证
企业类型
信用代码
310112001510759
成立日期
2015-05-29
注册资本
100
经营范围
从事生物科技技术领域内技术开发、技术咨询、技术服务、技术转让,实验分析仪器、化工产品及原料(除危险化学品、监控化学品、烟花爆竹、民用爆竹物品、易制毒化学品)、仪器仪表、环保设备、酒店用品、皮革制品、床上用品、电子产品的销售。【依法须经批准的项目,经相关部门批准后方可开展经营活动】
上海康朗生物科技有限公司
公司地址
上海市闵行区闵北路88弄1-30号第22栋BV145室
客服电话